When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision. 

Greg Piefer, PhD, chief executive and founder of Shine, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first sustained U.S. commercial supplier of molybdenum-99 in decades.

Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.

A new study is the first to show that men with biochemically recurrent prostate cancer who undergo PSMA PET/CT prior to salvage therapy have improved survival rates. 

Six physician professional associations recently made their case in a letter to Howard Lutnick, secretary of the U.S. Department of Commerce. 

Investments in MRI software, expanded CT offerings on both coasts, and new PET products have all helped increase advanced imaging to about 27.5% of RadNet's procedural volumes. 

The method utilizes findings from PET/MR imaging to differentiate between changes in tissue owed to treatment versus tumor progression.

The San Francisco-based company says the updates will accelerate radiology workflows by removing administrative burdens and freeing up radiologists to spend more time reviewing imaging exams instead.